Answer
QT prolongation was observed with eribulin mesilate on Day 8, but not Day 1, in an uncontrolled open-label ECG study of 26 patients, independently of eribulin concentration; eribulin should be avoided in congenital long QT syndrome.
Sources for this answer
- Eribulin 0.44 mg/ml solution for injectionZentiva · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked